Journal article
Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease
Abstract
BACKGROUND: Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.
OBJECTIVES: To assess the impact of perioperative IBD medications on the risk of postoperative infections within 30 days of surgery.
Authors
Law CC; Bell C; Koh D; Bao Y; Jairath V; Narula N
Journal
Cochrane Database of Systematic Reviews, Vol. 2021, No. 10,
Publisher
Wiley
DOI
10.1002/14651858.cd013256.pub2
ISSN
1361-6137
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Adrenal Cortex HormonesAdultAminosalicylic AcidsBiasColitis, UlcerativeConfidence IntervalsCrohn DiseaseFemaleHumansImmunologic FactorsInfectionsInflammatory Bowel DiseasesIntegrinsMaleObservational Studies as TopicOdds RatioPostoperative ComplicationsSurgical Wound DehiscenceSurgical Wound InfectionTime FactorsTumor Necrosis Factor-alpha